Christian Tucat

Christian Tucat is an accomplished professional with a strong background in the pharmaceutical and healthcare industries.

He holds an MBA in International Business from Erasmus University Rotterdam and has studied Business Administration and Economics at Universidad Argentina de la Empresa.

Christian has held significant leadership roles in reputed organizations, currently serving as the President of Syneos One and Real World & Late Phase at Syneos Health.

Prior to his current position, he was the EVP General Manager of Real World & Late Phase and Integrated Solutions Group (ISG) at Syneos Health, which was previously known as INC Research/inVentiv Health.

His previous roles include being the EVP General Manager of Real World & Late Phase and Global Consulting at INC Research, Senior Vice President of Business Development at INC Research, and General Manager EMEA at Theorem Clinical Research.

Christian has also served as the Vice President of Business Development for Europe & Asia Pacific at PRA International and has experience in sales and marketing at Eli Lilly and Company.

Furthermore, he has worked as a consultant in new product development and commercialization at GlaxoSmithKline and has been a Founding Partner at Jointelecom.com.

With a diverse and extensive career spanning various facets of the pharmaceutical and healthcare sectors, Christian Tucat brings a wealth of experience and expertise to his current role.

His educational background and professional journey have equipped him with a unique skill set that encompasses strategic planning, business development, leadership, and commercialization.

Christian's contributions to the industry have been significant, and his leadership roles speak to his abilities in driving growth and innovation in competitive environments.

Known for his dynamic approach and strategic vision, Christian Tucat continues to make a positive impact in the pharmaceutical and healthcare landscape.